Article
CvkR, a novel MerR-type transcriptional regulator, is a repressor of class 2 type V-K…
bioRxiv · 2022 · Marcus Ziemann
Key facts
| Title | CvkR, a novel MerR-type transcriptional regulator, is a repressor of class 2 type V-K CRISPR-associated transposase systems |
|---|---|
| First author | Marcus Ziemann |
| Journal | bioRxiv |
| Published | May 13, 2022 |
| DOI | 10.1101/2022.05.13.491168 |
| Product codes mentioned | KHO |
At a glance
- None FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1